Growth Metrics

Rigel Pharmaceuticals (RIGL) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 38.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.71%
Dec 31, 2025 44.23%
Sep 30, 2025 55.79%
Jun 30, 2025 63.51%
Mar 31, 2025 67.44%
Dec 31, 2024 40.26%
Sep 30, 2024 59.68%
Jun 30, 2024 -82.34%
Mar 31, 2024 36.98%
Dec 31, 2023 27.05%
Sep 30, 2023 58.97%
Jun 30, 2023 34.33%
Mar 31, 2023 -3.26%
Dec 31, 2022 -28.92%
Sep 30, 2022 3.46%
Jun 30, 2022 8.43%
Mar 31, 2022 -201.24%
Dec 31, 2021 -53.93%
Sep 30, 2021 19.73%
Jun 30, 2021 58.48%
Mar 31, 2021 5.31%
Dec 31, 2020 6.66%
Sep 30, 2020 -3.66%
Jun 30, 2020 10.45%
Mar 31, 2020 43.76%
Dec 31, 2019 6.30%
Sep 30, 2019 13.07%
Jun 30, 2019 3.50%
Mar 31, 2019 65.35%
Dec 31, 2018 41.46%
Sep 30, 2018 -27.50%
Jun 30, 2018 -14.96%
Mar 31, 2018 -49.09%
Dec 31, 2017 -9.14%
Sep 30, 2017 1.23%
Jun 30, 2017 0.90%
Mar 31, 2017 -7.80%
Dec 31, 2016 13.20%
Sep 30, 2016 -3.03%
Jun 30, 2016 4.72%
Mar 31, 2016 4.10%
Dec 31, 2015 14.35%
Sep 30, 2015 21.27%
Jun 30, 2015 5.45%
Mar 31, 2015 39.64%
Dec 31, 2014 6.90%
Sep 30, 2014 -11.15%
Jun 30, 2014 -3.87%
Mar 31, 2014 8.42%
Dec 31, 2013 -59.29%
Sep 30, 2013 -1.59%